Hong Kong’s Healthcare and Biotech Growth Sparks Innovations

Hong Kong, with its well-established infrastructure and strong financial market, is emerging as a leading force in the development of biotech companies, aiming to become a prominent hub in the field of health and medical innovation. Backed by supportive policies like the Chapter 18A regime that facilitates the listing of biotech companies, Hong Kong hosts over 260 listed healthcare firms, demonstrating the city’s commitment to fostering innovation in the sector. The city’s initiatives have turned it into a significant biotech fundraising center, attracting investments from various sources, including global institutional funds and investors from mainland China, propelling the industry’s growth….